Claritev Corp (CTEV)

Currency in USD
68.743
-2.868(-4.00%)
Real-time Data·
CTEV Scorecard
Full Analysis
Operates with a significant debt burden
CTEV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
68.74371.650
52 wk Range
4.80072.655
Key Statistics
Prev. Close
71.61
Open
71.03
Day's Range
68.743-71.65
52 wk Range
4.8-72.655
Volume
25.52K
Average Volume (3m)
139.62K
1-Year Change
602.61%
Book Value / Share
-2.43
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CTEV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
70.500
Upside
+2.56%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Claritev Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Claritev Corp Company Profile

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.

Claritev Corp Earnings Call Summary for Q2/2025

  • Q2 2025 revenue up 3.5% to $241.6M; stock dips 1.85% premarket to $38.79 despite 167% YTD return
  • Adjusted EBITDA grew 50.9%; full-year revenue guidance revised to flat to 2% increase
  • New AI initiatives and CompleteView platform launch announced; focus on cloud infrastructure
  • Cost reduction measures implemented, including facility closures and headcount reductions
  • High single-digit revenue growth projected for coming years; most new pipeline opportunities to convert by 2026
Last Updated: 06/08/2025, 14:26
Read Full Transcript

Compare CTEV to Peers and Sector

Metrics to compare
CTEV
Peers
Sector
Relationship
P/E Ratio
−1.7x−1.5x−0.6x
PEG Ratio
−0.04−0.010.00
Price/Book
−29.0x1.3x2.6x
Price / LTM Sales
1.2x1.6x3.3x
Upside (Analyst Target)
−1.6%22.8%39.0%
Fair Value Upside
Unlock20.4%4.9%Unlock

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 70.500
(+2.56% Upside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
-3.81 / -2.00
Revenue / Forecast
241.57M / --
EPS Revisions
Last 90 days

CTEV Income Statement

People Also Watch

179.25
ALAB
+2.93%
7.733
AMPX
+0.68%
765.68
AXON
+0.28%
30.28
VSAT
+7.34%
41.0900
ZEPP
+4.58%

FAQ

What Stock Exchange Does Claritev Trade On?

Claritev is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Claritev?

The stock symbol for Claritev is "CTEV."

What Is the Claritev Market Cap?

As of today, Claritev market cap is 1.15B.

What Is Claritev's Earnings Per Share (TTM)?

The Claritev EPS (TTM) is -40.80.

From a Technical Analysis Perspective, Is CTEV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Claritev Stock Split?

Claritev has split 1 times.

How Many Employees Does Claritev Have?

Claritev has 2700 employees.

What is the current trading status of Claritev (CTEV)?

As of 26 Aug 2025, Claritev (CTEV) is trading at a price of 68.74, with a previous close of 71.61. The stock has fluctuated within a day range of 68.74 to 71.65, while its 52-week range spans from 4.80 to 72.66.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.